The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Virus Nosode 4003
Virus Nosode · BACILLUS CALMETTE-GUERIN LIVE ANTIGEN, UNSPECIFIED SUBSTRAIN 30 [hp_X]/59mL; COXSACKIEVIRUS A21 30 [hp_X]/59mL; HUMAN HERPESVIRUS 5 30 [hp_X]/59mL; HUMAN HERPESVIRUS 4 30 [hp_X]/59mL; HAEMOPHILUS INFLUENZAE 30 [hp_X]/59mL; POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED) 30 [hp_X]/59mL; DALEA FOLIOLOSA WHOLE 30 [hp_X]/59mL; DRABA VERNA WHOLE 30 [hp_X]/59mL; VACCINIA VIRUS STRAIN NEW YORK CITY BOARD OF HEALTH LIVE ANTIGEN 30 [hp_X]/59mL; HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN 30 [hp_X]/59mL · Liquid · Oral · Professional Complementary Health Formulas
NDC 63083-4003-02 · 59 mL in 1 BOTTLE, DROPPER · UNAPPROVED HOMEOPATHIC · View full market →
Medicare Part D
Medicare Part D does not cover homeopathic products, which are not FDA-approved drugs.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Virus Nosode (Liquid)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Professional Complementary Health Formulas | BACILLUS CALMETTE-GUERIN LIVE ANTIGEN, UNSPECIFIED SUBSTRAIN 30 [hp_X]/59mL; COXSACKIEVIRUS A21 30 [hp_X]/59mL; HUMAN HERPESVIRUS 5 30 [hp_X]/59mL; HUMAN HERPESVIRUS 4 30 [hp_X]/59mL; HAEMOPHILUS INFLUENZAE 30 [hp_X]/59mL; POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED) 30 [hp_X]/59mL; DALEA FOLIOLOSA WHOLE 30 [hp_X]/59mL; DRABA VERNA WHOLE 30 [hp_X]/59mL; VACCINIA VIRUS STRAIN NEW YORK CITY BOARD OF HEALTH LIVE ANTIGEN 30 [hp_X]/59mL; HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN 30 [hp_X]/59mL | Jul 22, 2026 | Sep 2, 2026 |
| Professional Complementary Health Formulas | BACILLUS CALMETTE-GUERIN LIVE ANTIGEN, UNSPECIFIED SUBSTRAIN 30 [hp_X]/59mL; COXSACKIEVIRUS A21 30 [hp_X]/59mL; DALEA FOLIOLOSA WHOLE 30 [hp_X]/59mL; DRABA VERNA WHOLE 30 [hp_X]/59mL; HAEMOPHILUS INFLUENZAE 30 [hp_X]/59mL; HUMAN HERPESVIRUS 4 30 [hp_X]/59mL; HUMAN HERPESVIRUS 5 30 [hp_X]/59mL; HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN 30 [hp_X]/59mL; POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED) 30 [hp_X]/59mL; VACCINIA VIRUS STRAIN NEW YORK CITY BOARD OF HEALTH LIVE ANTIGEN 30 [hp_X]/59mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Virus Nosode 4003 — NDC 63083-4003-02," retrieved September 3, 2026, https://drugdashboards.com/drug/63083400302.
Free to cite with attribution — see how the data is put together.